Two Onc Docs

This week’s episode  is part 2 of 2023 updates focusing on treatment options for localized breast cancer. We will discuss important details on radiation, as well as therapies based on ER/PR/her2 receptor status.

We are continuing our 2023 updates, this week’s episode will be an intro to breast cancer. Today’s will include high yield tips on screening, prevention, ductal carcinoma in situ DCIS, lobular carcinoma in situ LCIS, as well as introduce invasive localized disease.

This week’s episode is a quick one, focusing on heparin induced thrombocytopenia (HIT). We will go over the the pathophysiology, diagnosis and treatment of HIT.

This week’s episode will be focusing on Hematopoietic Stem Cell Transplant. We will go over the important details on the different types of SCT, where stem cells can be collected from, conditioning regimens as well as complications to be aware of for boards. This is a robust field so remember by no means is this short episode all of SCT but rather a quick overview for highest yield information for boards

Today’s episode is covering the treatment options for M0 castrate resistant prostate cancer as well as metastatic castrate-sensitive and castrate-resistant prostate cancer, including some 2023 updates.

Today’s episode is a 2023 update on the management of metastatic colon cancer. This will include an overview of molecular studies, treatment options and their toxicities.

Today’s episode is a 2023 update on what you need to know regarding early stage colon cancer. We will go over all the important details on the diagnosis, presentation, diagnostic work-up, staging, treatment, and surveillance.

This week’s episode will be focusing on hemolytic anemia. We will primarily focus on acquired forms of hemolytic anemia which include warm autoimmune hemolytic anemia (WAIHA), cold agglutinin disease (CAD), paroxysmal cold hemoglobinuria (PCH), and briefly cover a few other key differentials.